The Female Pelvic Implants Market Size is valued at 121.6 Million in 2022 and is predicted to reach 188.6 Million by the year 2031 at an 5.0 % CAGR during the forecast period for 2023-2031.
The pelvic implant is a woven synthetic netting designed from polypropylene implemented in a surgical procedure under the urethra like a sling or hammock to keep the urethra in the correct position. It is a range of synthetic or biological implants such as Vaginal Mesh Implants, Vaginal Sling, and Vaginal Graft Implants that can be used to deliver additional support when repairing weakened or damaged tissue. The pelvic implant is placed into the pelvis for a various range of conditions, such as usually pelvic organ prolapse and stress urinary incontinence.
The rising prevalence of pelvic organ prolapse and stress urinary incontinence is propelling the female pelvic implants market. The market is also driven by growing awareness among women regarding in treatment of POP and SUI, rising health care expenditure, along with augmented research and development activities across the globe. However, the female pelvic implants market is perceiving a sluggish growth on account of several complications associated with implantation procedures.
Market Segmentation
The Global Female Pelvic Implants market is categorized on the basis of product, Indication Type, End-user, and region. On the basis of product type, the market is segmented into Vaginal Mesh Implants, Vaginal Sling, and Vaginal Graft Implants. On the basis of Indication Type, the market is segmented into Pelvic Organ Prolapse and Stress Urinary Incontinence. On the basis of end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some of The Key Players in The Female Pelvic Implants Market:
- Johnson & Johnson
- Coloplast A/S
- Becton, Dickinson and Company (C. R. Bard, Inc)
- Boston Scientific Corporation
- pfm medical ag
- Cook Medical
- Betatech Medical
- Dipromed Srl
- Promedon Group
- Caldera Medical
- Cousin Biotech
- THT bio-science
- DynaMesh / FEG Textiltechnik
- American Medical Systems
- ABISS
- Other Prominent Players
The Female Pelvic Implants Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 121.6 Million |
|
Revenue Forecast In 2031 |
USD 188.6 Million |
|
Growth Rate CAGR |
CAGR of 5.0 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Indication, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Johnson & Johnson, Coloplast A/S, Becton, Dickinson, and Company (C. R. Bard, Inc), Boston Scientific Corporation, pfm medical ag, Cook Medical, Betatech Medical, Dipromed Srl, Promedon Group, Caldera Medical, Cousin Biotech, THT bio-science, DynaMesh / FEG Textiltechnik, American Medical Systems, and ABISS, and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
